<unk>  is a non-nucleoside reverse transcriptase inhibitor that is FDA approved for the treatment of HIV-1 in adults and children at least 3 months old and weighing at least 3.5 kg.   Common adverse reactions include impaired concentration, abnormal dreams, rash, dizziness, nausea, headache, fatigue, insomnia and vomiting.
Efavirenz
Saquinavir
Zidovudine
Lamivudine
Entecavir
Fosamprenavir
Telbivudine
Nelfinavir